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Introduction
Protein deglycase DJ-1 is coded by the human PARK7 gene on chromosome 1 (1p36.12-1p36.33) [1] , and also named as Parkinson disease protein 7 due to the fact that DJ-1 was first discovered in Parkinson's disease (PD) patients [2] . DJ-1 is a member of the DJ-1/Hsp31/PfpI superfamily [3] . With a size of 20 kDa [4] , DJ-1 consists of 189 amino acids (9 α-helices and 7 β-strands in total) [5] and it is usually presented as a dimer which is important for its biological activity. Mutations destroy the dimer structure of DJ-1. For instance, L166P and M26I weaken its biological activity [6] .
The DJ-1 protein is abundantly expressed in more than 22 human tissues [7] . DJ-1 is associated with multiple biological functions, such as mitochondrial function regulation [8] , transcriptional regulation, molecular chaperone [9] , glyoxalase [10] , cysteine protease regulation, glutathione regulation [11, 12] , dopamine regulation [13] , and the subunit of RNA-binding protein regulation. Of most importance, dependable findings revealed that DJ-1 possesses an antioxidant activity and plays a role as a redox activated chaperone [9] in cytoprotective function under stimuli challenge [14, 15] . DJ-1 has 3 cysteine residues, Cys-106, Cys-46 and Cys-53, with Cys-106 being the active site [16] . DJ-1 may exhibit its anti-oxidative defence through oxidation of Cys-106 to regulate transcription factors instead of removing ROS directly.
DJ-1, an important endogenous antioxidant, is expected to be a target of mechanism-oriented therapy for neurodegenerative diseases, cardiovascular diseases, and cancers [17] . Many ocular diseases are associated with oxidative stress but DJ-1 is never reviewed in ocular diseases. In this review, we discuss the role of DJ-1 in the pathogenesis of ocular diseases and the mechanism to target DJ-1 for treatment of these diseases.
Fuchs endothelial corneal dystrophy (FECD)
FECD is a severe corneal dystrophy with slow, progressive loss of corneal endothelial cells resulting in corneal edema and vision loss at the late stage. Currently, corneal transplantation is the mainstream treatment option to restore the vision [18] . Oxidative stress has been considered to exert an important role in the apoptosis of corneal endothelial cells (CECs) in FECD. Nuclear factor erythroid 2-related factor 2
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International Publisher (Nrf2) is a foremost transcription regulator of cellular protector against oxidative stress. DJ-1 is a protein stabilizer of Nrf2 and was markedly decreased at both mRNA and protein levels of CECs in FECD. Under oxidative stress, DJ-1 protein synthesis was significantly up-regulated in normal CECs. Whereas decreased levels of DJ-1 was found in FECD at baseline, which-diminished Nrf2 nuclear transloncation and accelerated CECs apoptosis. The pathway of DJ-1/Nrf2 axis could serve as a new therapeutic target of FECD by slowing CEC degeneration in FECD [19] . Sulforaphane (SFN) is thought as an ''indirect antioxidant'' and can augment effects on varieties of antioxidant genes. In Alireza Ziaei et Al. study, SFN enhanced nuclear translocation of Nrf2 in human FECD specimens under tert-Butyl hydroperoxide (tBHP) induced oxidative stress and led to increased DJ-1 synthesis. This proof-of-concept investigation indicated that DJ-1 may protect FECD against oxidative stress by activating Nrf2-antioxidant response element (ARE) pathway [20] . Ultraviolet A (UV-A), with a wavelength of 320-400 nm can initiate cell apoptosis indirectly by producing reactive oxygen species (ROS). Small interfering RNA (siRNA) of DJ-1 was transfected into the normal human corneal endothelial cell line (HCECi) to obtain the DJ-1-deficient CECs. Increased ROS overproduction and decreased DJ-1, nuclear Nrf2 proteins were found in DJ-1 siRNA-treated cells when compared to controls. DJ-1-deficient CECs exhibited a vulnerable response to UV-A irradiation, and the declined in DJ-1 led to activation of caspase-3 and phospho-p53 under the oxidative stress. And plays a central role in the execution-phase of cell apoptosis, indicating that DJ-1 may serve a protective role against UV-A-induced apoptosis by inhibiting phospho-53-mediated apoptosis pathway. Down-regulation of DJ-1 also attenuated Nrf2 nuclear translocation, causing the decreasement of transcription of antioxidant genes (NQO1 and HO-1) in DJ-1-deficient CECs and weakened antioxidant defense [19] .
DJ-1 may serve as a potential treatment option for corneal endothelial disorders, such as FECD. Further studies are required to understand the role of DJ-1 in FECD more precisely.
Age-related macular degeneration (AMD)
AMD is a common retinal disease and also a leading cause of irreversible vision loss in the old patients. The degeneration of retinal pigment epithelium (RPE) cells, which is the pigmented cell layer just outside the neurosensory retina that nourishes retinal visual cells, in association with oxidative stress is related to AMD pathogenesis.
The photoreceptors and RPE in DJ-1-deficient retinas exhibited signs of physiological dysfunction, accompanied by the increased carbonyl content (protein oxidation product), nitric oxide synthase (iNOS, an oxidative stress marker) and decreased Nrf2 expression (antioxidant transcriptional regulator) in retina/RPE lysates of DJ-1 KO mice. Moreover, a single tail vein injection of NaIO3 (an oxidizing reagent) significantly accelerated RPE degeneration in DJ-1 KO mice [21] . Reduced photoreceptor activity was also found by the ERG in old DJ-1 KO retinas when compared to age-matched controls. These results suggest that DJ-1 is a protecting factor for RPE/photoreceptors against the oxidative stress (such as ageing) by regulating Nrf2 signaling. Therefore, DJ-1 may serve as a potential target for the prevention of the geographic atrophy and vision loss in AMD [22] .
Cataract
Cataract is the leading cause of blindness worldwide. Increasing age is considered as the main contributor to cataract, and the ageing eyes are susceptible to be at extensive risk to oxidative stress [23] . DJ-1 with oxidized cysteine at vital sites was also found to be dramatically expressed in lens fibers [24] .
The experiment demonstrated that the cysteine residues of DJ-1, Cys46 and Cys53, were found to be oxidized in aged cataractous human lenses. Similar results were also found in glutathione-depleted mouse (LEGSKO) lenses and in vitro oxidation model triggered by H2O2 when compared to controls. As long-lived proteins, the lens proteins are inclined to damage accumulation. Substantial evidence points out that cataract is associated with disulfide-linked high molecular weight crystal aggregation. The oxidation of DJ-1 protein was closely related to disulfide cross-linking. The disulfide ratio of the Cys46 and Cys53 in an aged human lens is much higher than the controls. Similar results were also detected in Cys46 and Cys53 oxidation in LEGSKO vs. age-matched mouse lens and in vitro modelling samples.
The above results indicate that DJ-1 is a significant oxidation site in the lens via the disulfide cross-linking [25] .
Ocular neurodegenerative diseases
Ocular neurodegenerative diseases, such as glaucoma, optic neuropathies are characterized by the damage of the optic nerve as well as progressive deterioration of retinal ganglion cells (RGCs), which constitute significant elements for chronic visual injury [26] [27] [28] . Oxidative stress plays an important role in the pathogenesis of ocular neurodegenerative diseases [29] . Glutathione level, a significant antioxidant in the retina, is decreased markedly in plasma of glaucoma patients [30, 31] . The antioxidant drug, Geranylgeranylacetone (GGA) is effective in protecting RGCs in glaucoma mouse models [32] . Optic neuritis (ON), an optic nerve disease, is strongly associated with inflammatory demyelination [33] and present symptoms in 20% of multiple sclerosis (MS) patients [34] . Oxidative stress is indicated to play a key role in the pathogenesis of MS [35] and antioxidants are demonstrated to be effective in ameliorating the inflammation of the optic nerve. For instance, natural antioxidant lipoic acid [36] and spermidine [37] 
Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway
Nrf2 is a master transcription factor associated with oxidative stress and can modify the basal and inducible expressions of several antioxidant genes [38] . Nrf2 KO mice are vulnerable to the ocular diseases and are related to oxidative stress. Genetic ablation of Nrf2 can aggravate irreversible RGCs apoptosis and visual deficits in the murine model [39] .Gene therapy with Nrf2 could reduce RGCs degeneration [40] . DJ-1 stabilizes Nrf2 and induces the expression of antioxidant thioredoxin 1 through the Nrf2 pathway [41] . These findings above indicate that DJ-1 could be a potential therapeutic target for ocular neurodegenerative diseases via regulating the activation of Nrf2.
PI3K/Akt pathway
The phosphoinositide 3-kinase (PI3K)/Akt signaling pathway plays an important part in blocking oxidative stress [42] and functions as a neuroprotective effect for the injured RGCs [43] . Activation of the PI3K/Akt pathway provides a possible therapeutic target for RGCs damage in retinal ischemia [44, 45] . Phosphatase and Tensin homolog deleted on chromosome 10 (PTEN) is a negative regulator of PI3K/Akt pathway [46] . DJ-1 activated PI3K/Akt pathway and exhibited its cytoprotective role via the inhibition of PTEN [47, 48] indicating that DJ-1 may serve as a strategy to achieve neuroprotection of RGCs in ocular neurodegenerative diseases.
ASK1 pathway
Apoptosis signal-regulating kinase 1 (ASK1) is a member of the stress-responsive mitogen-activated protein kinase kinase kinase (MAP3K) family and plays a vital role in regulating oxidative stress [49] or cytokine-induced apoptosis [50] . ASK1 is activated by the phosphorylation of a vital threonine residue in the oxidative stress state [51] . ASK1 deletion reduced the oxidative stress level and the factors which cause oxidative stress, for instance, TNF-α [52] . ASK1 deletion prevented RGC apoptosis and increased RGC survival in mice model of glaucoma [53] . This experiment shows that ASK1 is a negative factor for RGC, and ASK1 inhibition can be an effective target for treatment of glaucoma. Under oxidative stress, DJ-1 binds with ASK1 via the Cys-106 and forms the mixed disulfide bonds, which provide cytoprotection in mouse embryonic fibroblast [54, 55] . These results indicate that DJ-1 may provide a promising approach for the treatment of glaucoma.
The above pathway describes the role of DJ-1 in the protection of RGCs. DJ-1-related treatment, by targeting oxidative stress could be a promising step in the management of ocular neurodegenerative diseases.
Uveal Melanoma (UM)
DJ-1 was found as a putative oncogenic gene years ago [56] . Accumulate evidence have shown that DJ-1 is frequently overexpressed and secreted in several tumor cells, for example, prostate cancer [57] , hepatocellular carcinoma [58] , non-small cell lung carcinoma (NSCLC) [59] , laryngeal squamous cell carcinoma [60] , and esophageal squamous cell carcinoma (ESCC) [61] , indicating that DJ-1 overexpression is a regular event in cancer cells.
Choroidal nevi, which is referred to as pigmented lesions are usually benign. However, Choroidal nevi may develop to UM, and the risk of malignant transformation is estimated 0.011%.
Elevated serum levels of DJ-1 in choroidal nevi patients had a significant correlation with clinical risk factors of malignant transformation (e.g. nevus thickness > 1.5 mm, a large basal diameter > 8 mm). DJ-1 level was shown to have a positive correlation with clinical risk factors for choroidal nevi growth and may be a promising biomarker of malignancy [62] .
UM, is a cancer of the melanocytes in the uvea (the iris, ciliary body, and choroid) of the eye. It is considered as the most frequent primary intraocular malignant growth in adults with high risk of blood disseminating and hepatic metastases [63, 64] . UM-A, a primary and well-characterized UM cell, is proved to be a valuable cell model for studying UM in vitro. DJ-1 protein could be secreted by both UM-A and other UM cell lines cultured in vitro, but not by normal melanocytes, indicating that DJ-1 protein may serve as a potential serum marker for UM [65] . DJ-1 level in serum of patients with metastatic UM was reported to be significantly upregulated, either compared with UM disease-free controls (at last 10 years following primary UM treatment) or compared with normal healthy controls. The study further indicated that overexpression of DJ-1 may be associated with metastatic UM. Consequently, DJ-1 could be a potential serological biomarker for detection of UM metastases in patients at an early stage [66, 67] .
To summarize, DJ-1 is closely related to the occurrence and development of UM and can be used as a biomarker for UM diagnosis and prognosis evaluation. However, the mechanism is still not clear and more investigations are still needed.
Conclusions
DJ-1 is expressed in various ophthalmological diseases and the function of DJ-1, as well as the underlying pathway involved varies in different diseases. As discussed above, DJ-1 plays a role as an antioxidant in FECD, AMD, cataracts, and ocular neurodegenerative diseases. Both in vitro and in vivo studies showed that it may exert protective role through various pathways (Nrf2 pathway, PI3K/Akt pathway, ASK1 pathway). Furthermore, DJ-1 is overexpressed in the progression of UM and can be used as a biomarker for UM diagnosis. Thus, DJ-1 could be a promising target directing the future treatment of related ocular diseases. [20]
In vitro CECs from ex vivo corneas of DJ-1 knockout mice DJ-1-deficient CECs exhibited the vulnerable response to UV-A irradiation, and the decline in DJ-1 led to activation of caspase-3 and phospho-p53 under the oxidative stress, which plays a central role in the execution-phase of cell apoptosis. DJ-1 may serve a protective role against UV-A-induced apoptosis by inhibiting phospho-53-mediated apoptosis pathway.
[19]
AMD
In vivo DJ-1 KO mice DJ-1 is a protecting factor for RPE/photoreceptors against the oxidative stress (such as aging) by regulating Nrf2 signaling and DJ-1 may serve as a potential target for the prevention of the geographic atrophy and vision loss in AMD.
[ [41].
In vitro Mouse NIH3T3 cells Activation of the PI3K/Akt pathway is often induced by substances able to prevent RGC death in retinal ischemia. DJ-1 activated PI3K/Akt pathway and exhibited its cytoprotective role via the inhibition of PTEN.
[ 47, 48] In vivo mice model of glaucoma ASK1 deletion prevented RGC apoptosis and increased RGC survival in mice model of glaucoma.
[53]
In vitro mouse embryonic fibroblast DJ-1 can bind with ASK1 via the Cys-106 under oxidative stress.
[54]
UM In vitro UM cell lines DJ-1 protein could be secreted into the bloodstream by both UM-A and other UM cell lines cultured in vitro, but not by normal melanocytes, indicating that DJ-1 protein may serve as a potential serum marker for UM.
[65]
Abbreviations: FECD, Fuchs endothelial corneal dystrophy; SFN, Sulforaphane; AMD, Age-related macular degeneration; Nrf2, Nuclear factor erythroid 2-related factor 2; tBHP, tert-Butyl hydroperoxide; CECs, corneal endothelial cells; PI3K, phosphoinositide 3-kinase; RGC, retinal ganglion cells; PTEN, Phosphatase and Tensin homolog deleted on chromosome 10; ASK1, Apoptosis signal-regulating kinase 1; UM, uveal melanoma
